Robert Evans to Cystitis, Interstitial
This is a "connection" page, showing publications Robert Evans has written about Cystitis, Interstitial.
Connection Strength
4.565
-
Walker SJ, Plair A, Hemal K, Langefeld CD, Matthews C, Badlani G, Zambon J, Heath H, Evans RJ. Bladder Hydrodistention Does Not Result in a Significant Change in Bladder Capacity for Interstitial Cystitis/Bladder Pain Syndrome Patients. Urology. 2019 Oct; 132:81-86.
Score: 0.678
-
Koslov DS, Vilson F, Colaco M, Terlecki RP, Evans RJ. Impact of Cystectomy With Urinary Diversion Upon Tracked Receipt of Opioid Prescriptions Among Patients With Interstitial Cystitis/Bladder Pain Syndrome. Urology. 2018 Apr; 114:83-86.
Score: 0.606
-
Walker SJ, Zambon J, Andersson KE, Langefeld CD, Matthews CA, Badlani G, Bowman H, Evans RJ. Bladder Capacity is a Biomarker for a Bladder Centric versus Systemic Manifestation in Interstitial Cystitis/Bladder Pain Syndrome. J Urol. 2017 08; 198(2):369-375.
Score: 0.574
-
Colaco MA, Evans RJ. Current recommendations for bladder instillation therapy in the treatment of interstitial cystitis/bladder pain syndrome. Curr Urol Rep. 2013 Oct; 14(5):442-7.
Score: 0.455
-
Evans RJ. Sacral neuromodulation is an effective treatment for interstitial cystitis/bladder pain syndrome: con. J Urol. 2012 Dec; 188(6):2044-5.
Score: 0.423
-
Patel BN, Evans RJ. Overactive bladder and pain: management strategies. Curr Urol Rep. 2010 Nov; 11(6):379-84.
Score: 0.372
-
Evans RJ, Sant GR. Current diagnosis of interstitial cystitis: an evolving paradigm. Urology. 2007 Apr; 69(4 Suppl):64-72.
Score: 0.290
-
Wu EQ, Birnbaum H, Kang YJ, Parece A, Mallett D, Taitel H, Evans RJ. A retrospective claims database analysis to assess patterns of interstitial cystitis diagnosis. Curr Med Res Opin. 2006 Mar; 22(3):495-500.
Score: 0.269
-
Schachar JS, Evans RJ, Parks GE, Zambon J, Badlani G, Walker SJ. Histological evidence supports low anesthetic bladder capacity as a marker of a bladder-centric disease subtype in interstitial cystitis/bladder pain syndrome. Int Urogynecol J. 2019 11; 30(11):1863-1870.
Score: 0.169
-
Matthews CA, Deveshwar SP, Evans RJ, Badlani G, Walker SJ. Small fiber polyneuropathy as a potential therapeutic target in interstitial cystitis/bladder pain syndrome. Int Urogynecol J. 2019 11; 30(11):1817-1820.
Score: 0.169
-
Colaco M, Koslov DS, Keys T, Evans RJ, Badlani GH, Andersson KE, Walker SJ. Correlation of gene expression with bladder capacity in interstitial cystitis/bladder pain syndrome. J Urol. 2014 Oct; 192(4):1123-9.
Score: 0.119
-
Parsons CL, Proctor J, Teichman JS, Nickel JC, Davis E, Evans R, Zupkas P, Phillips C, Shaw T, Naidu N, Argade S. A multi-site study confirms abnormal glycosylation in the Tamm-Horsfall protein of patients with interstitial cystitis. J Urol. 2011 Jul; 186(1):112-6.
Score: 0.096
-
Sand PK, Kaufman DM, Evans RJ, Zhang HF, Alan Fisher DL, Nickel JC. Association between response to pentosan polysulfate sodium therapy for interstitial cystitis and patient questionnaire-based treatment satisfaction. Curr Med Res Opin. 2008 Aug; 24(8):2259-64.
Score: 0.079
-
Moldwin RM, Evans RJ, Stanford EJ, Rosenberg MT. Rational approaches to the treatment of patients with interstitial cystitis. Urology. 2007 Apr; 69(4 Suppl):73-81.
Score: 0.072
-
Evans RJ, Stanford EJ. Current issues in the diagnosis of painful bladder syndrome/interstitial cystitis. J Reprod Med. 2006 Mar; 51(3 Suppl):241-52.
Score: 0.067
-
Payne CK, Mosbaugh PG, Forrest JB, Evans RJ, Whitmore KE, Antoci JP, Perez-Marrero R, Jacoby K, Diokno AC, O'Reilly KJ, Griebling TL, Vasavada SP, Yu AS, Frumkin LR. Intravesical resiniferatoxin for the treatment of interstitial cystitis: a randomized, double-blind, placebo controlled trial. J Urol. 2005 May; 173(5):1590-4.
Score: 0.063
-
Nickel JC, Barkin J, Forrest J, Mosbaugh PG, Hernandez-Graulau J, Kaufman D, Lloyd K, Evans RJ, Parsons CL, Atkinson LE. Randomized, double-blind, dose-ranging study of pentosan polysulfate sodium for interstitial cystitis. Urology. 2005 Apr; 65(4):654-8.
Score: 0.063